Vivos (RDGL) Enterprise Value Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.56% |
| Sep 30, 2025 | -80.77% |
| Jun 30, 2025 | -54.29% |
| Mar 31, 2025 | -138.18% |
| Dec 31, 2024 | -38.95% |
| Sep 30, 2024 | 20.74% |
| Jun 30, 2024 | 1.39% |
| Mar 31, 2024 | 2.95% |
| Dec 31, 2023 | 6.67% |
| Sep 30, 2023 | 22.68% |
| Jun 30, 2023 | -66.44% |
| Mar 31, 2023 | -15.60% |
| Dec 31, 2022 | -6.22% |
| Sep 30, 2022 | -0.06% |
| Jun 30, 2022 | 51.46% |
| Mar 31, 2022 | 51.36% |
| Dec 31, 2021 | -77.73% |
| Sep 30, 2021 | -13,202.47% |
| Jun 30, 2021 | -769.85% |
| Dec 31, 2020 | -4,334.05% |
| Sep 30, 2020 | 90.58% |
| Jun 30, 2020 | -2,827.02% |
| Dec 31, 2019 | -270.97% |
| Mar 31, 2019 | -261,081.25% |
| Dec 31, 2018 | 33.94% |
| Mar 31, 2018 | 99.93% |
| Dec 31, 2017 | 70.18% |
| Sep 30, 2017 | -147,300.00% |
| Jun 30, 2017 | -201,784.70% |
| Mar 31, 2017 | 90.44% |
| Dec 31, 2016 | 84.42% |
| Sep 30, 2016 | 99.80% |
| Jun 30, 2016 | 99.30% |
| Mar 31, 2016 | -9,877.34% |
| Dec 31, 2015 | -88,093.10% |
| Sep 30, 2015 | -384.98% |
| Jun 30, 2015 | 79.22% |
| Mar 31, 2015 | 97.29% |
| Sep 30, 2014 | 94.18% |
| Jun 30, 2014 | -1,707.07% |
| Mar 31, 2014 | -35.72% |
| Sep 30, 2013 | 44.66% |
| Jun 30, 2013 | 49.53% |
| Dec 31, 2012 | 87.80% |
| Sep 30, 2012 | -154.03% |
| Jun 30, 2012 | -169.74% |
| Dec 31, 2011 | 91.08% |
| Sep 30, 2011 | 96.65% |
| Jun 30, 2011 | 90.00% |